SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-19-006090
Filing Date
2019-04-29
Accepted
2019-04-29 17:15:30
Documents
1
Period of Report
2019-04-29
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 684808
  Complete submission text file 0001493152-19-006090.txt   685959
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35817 | Film No.: 19777079
SIC: 8071 Services-Medical Laboratories
Assistant Director 9